Aquatic Capital Management LLC Ascendis Pharma A/S Transaction History

Aquatic Capital Management LLC

  • $3.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$123.45 - $159.4 $530,835 - $685,420
4,300 New
4,300 $650,000
Q3 2023

Nov 14, 2023
SELL
$86.5 - $103.97 $8,650 - $10,397
-100 Reduced 3.45%
2,800 $262,000
Q2 2023

Aug 14, 2023
BUY
$69.96 - $97.84 $27,983 - $39,136
400 Added 16.0%
2,900 $259,000
Q1 2023

May 15, 2023
BUY
$104.9 - $126.78 $262,250 - $316,950
2,500 New
2,500 $268,000

Others Institutions Holding ASND

# of Institutions
244
Shares Held
58.8M
Call Options Held
250K
Put Options Held
377K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.61B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email